Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment
Jia, Menglei, Yuan, Zhongwen, Yu, Hang, Feng, Senling, Tan, Xiaoxiao, Long, Zijing, Duan, Yanrong, Zhu, Wenting, Yan, Pengke
Published in Biomedicine & pharmacotherapy (01.07.2024)
Published in Biomedicine & pharmacotherapy (01.07.2024)
Get full text
Journal Article
Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
Feng, Senling, Zhou, Huifang, Wu, Deyan, Zheng, Dechong, Qu, Biao, Liu, Ruiming, Zhang, Chen, Li, Zhe, Xie, Ying, Luo, Hai-Bin
Published in Acta pharmaceutica Sinica. B (01.02.2020)
Published in Acta pharmaceutica Sinica. B (01.02.2020)
Get full text
Journal Article
Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway
Feng, Senling, Li, Yuting, Huang, Hanhui, Huang, Hongliang, Duan, Yingying, Yuan, Zhongwen, Zhu, Wenting, Mei, Zhengrong, Luo, Lianxiang, Yan, Pengke
Published in European journal of pharmacology (05.09.2023)
Published in European journal of pharmacology (05.09.2023)
Get full text
Journal Article
Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha
Lin, Wanjun, Huang, Jiajun, Liao, Xiaolin, Yuan, Zhongwen, Feng, Senling, Xie, Ying, Ma, Wenzhe
Published in Pharmacological research (01.09.2016)
Published in Pharmacological research (01.09.2016)
Get full text
Journal Article